openPR Logo
Press release

XClinical and IDDI: The best of 2 worlds

03-28-2011 11:28 AM CET | Leisure, Entertainment, Miscellaneous

Press release from: XClinical GmbH

XClinical GmbH

XClinical GmbH

The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system

XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the web-based open interface of IDDI’s ID-netTM to XClinical’s EDC system MARVIN at the DIA Annual EuroMeeting in Geneva.

About ID-netTM

ID-netTM is an Interactive Web Response System (IWRS) for centralized randomization and treatment allocation developed by IDDI in 2000 and used for all its randomization trials. More than 150 studies with over 100,000 patients have been conducted with the system. ID-netTM supports all types of randomization schemes and includes various features, such as study drug tracking and inventory management as well as patient registration, code break and withdrawal. In 2008, IDDI decided to implement XClinical’s EDC system MARVIN for conducting EDC trials in parallel of ID-netTM for randomization and drug supply management.

Web-based open interface to MARVIN

In May 2010, both companies’ Managing Directors – Dr. Philippe Verplancke and Damien Tremolet – initiated the project to build up a web-based open interface between ID-netTM and MARVIN. “We really appreciated the initiative, as this partnership reflects XClinical’s business strategy,” states Dr. Philippe Verplancke, CEO of XClinical. “The integration with IDDI’s randomization suite is an excellent example of the benefits of effectively bundling competencies.” XClinical could thus extend its own randomization capabilities with sophisticated dynamic randomization schemes offered by IDDI.
In May 2010, a multi-disciplinary project team from both companies wrote the specification documents and jointly tested the software implementations. ”The open interfaces of MARVIN and ID-netTM will facilitate connection with third party systems. The immediate return ,though, will be a single front-end to site personnel for EDC and randomization”, says Damien Tremolet, CEO of IDDI. “Today, software products providing such interfaces gain more acceptance. Furthermore, we are convinced of the positive outcome this new strategic partnership will generate.“
For more information on the interface of ID-netTM to MARVIN, visit XClinical at booth No. 1220 at the DIA Annual EuroMeeting in Geneva, Switzerland, taking place from March 28 to 30.

Or contact IDDI and XClinical directly:

Your contact at IDDI:
Catherine Indekeu
Phone: +32 / (0)10 / 621557
E-mail: catherine.indekeu@iddi.com
www.iddi.com
Your contact at XClinical
Dr. Philippe Verplancke
Phone: +49 / (0)89 / 452277 – 5100
E-mail: philippe.verplancke@xclinical.com
www.xclinical.com

About IDDI
IDDI (International Drug Development Institute) provides biostatistical and eClinical services including data management and innovative information systems to the pharmaceutical and biotechnology sector. ID-netTM uses web-based and/or voice technologies to deploy applications anywhere in the world in accordance with the trial protocol requirements. IDDI is based in Louvain-la-Neuve, Belgium, with offices in Cambridge, MA and Houston, TX, USA. Its 24/7 support team covers all countries.

About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM-certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).

Katharina Lang, XClinical GmbH, Phone: +49 (0)89 / 45 22 77 – 52 20
E-mail: press@xclinical.com

XClinical GmbH
Siegfriedstrasse 8
80803 Munich / Germany

Katharina Lang
kl@xclinical.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release XClinical and IDDI: The best of 2 worlds here

News-ID: 168290 • Views: 2453

More Releases from XClinical GmbH

XClinical integrates INCA, Medical Coding software, with its EDC system MARVIN
XClinical releases version 1.6. of its coding system INCA XClinical GmbH, Munich, Germany, May 8, 2014 – XClinical, a global provider of eClinical solutions, today announces the availability of INCA version 1.6, medical coding software featuring MedDRA and WHODrug dictionaries, including an automated web interface to EDC systems such as MARVIN. INCA (“Integrated Coding Architecture”) is a web-based application that enables users to classify health related data such as patient medications and
XClinical CRO Executive Forum
XClinical hosts its first CRO Executive Forum on May 10, 2011 in Aying, Germany. XClinical GmbH, Munich, Germany – April 14, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, hosts its first CRO Executive Forum especially designed for CEOs of CROs on May 10, 2011 in Aying, Germany. The concept In 2010, XClinical started to provide
XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical presents the initiative “MARVIN4KIDS” at the DIA Annual EuroMeeting in Geneva XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30. “MARVIN4KIDS” MARVIN4KIDS is an XClinical
XClinical’s review of 2010
XClinical looks back on an innovative and extremely successful year XClinical GmbH, Munich, Germany – February 15th, 2011 – XClinical, European vendor of innovative software products for eClinical trials, well known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, had a very successful and innovative business year. Extended workforce Constant growth in the past years and the successful market relaunch of the STUDY COMPOSER as a standalone software tool

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical